Literature DB >> 24733341

Medication-related emergency department visits and hospitalizations among older adults.

Imaan Bayoumi1, Lisa Dolovich, Brian Hutchison, Anne Holbrook.   

Abstract

OBJECTIVE: To identify medications that have a high risk of adverse drug effects (ADEs) among seniors, using data from publicly available administrative databases.
DESIGN: Cross-sectional study using the Discharge Abstracts Database (DAD) (which contains data on acute care institutions in all provinces and territories except Quebec), the National Ambulatory Care Reporting System (NACRS) (which contains data on emergency department [ED] visits in Ontario), and the IMS Brogan database Canadian CompuScript.
SETTING: Canada. PARTICIPANTS: Adults 65 years of age and older with diagnostic codes for drugs, medicaments, and biologic substances causing adverse effects in therapeutic use. MAIN OUTCOME MEASURES: Adverse drug events from 2006 to 2008 associated with hospitalizations and ED visits among adults 65 years of age and older were identified by the DAD and the NACRS. The medications most frequently prescribed by primary care providers in 2008 were identified using data from Canadian CompuScript.
RESULTS: From 2006 to 2008, the DAD identified 92 141 ADEs among older adults, and the NACRS identified 23 845 ADEs among older adults in Ontario EDs, which represented 2.9% of inpatients and 0.8% of ED patients (21.5% of whom were admitted to hospital). Drugs implicated in the DAD ADEs included anticoagulants (15.4%), antineoplastic agents (10.6%), opioids (9.2%), and nonsteroidal anti-inflammatory drugs (6.5%); drugs included in the ADEs of ED visits were anti-infective agents (15.9%), anticoagulants (14.2%), antineoplastic agents (9.6%), and opioids (7.3%).
CONCLUSION: Among older adults, the drug classes most often associated with causing harm in the hospital setting and occurring out of proportion to the frequency prescribed were anticoagulants, opioids, antibiotics, and cardiovascular drugs. Thus, these drug classes should be the focus of quality improvement efforts in primary care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733341      PMCID: PMC4046528     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

1.  The incidence of adverse drug events in two large academic long-term care facilities.

Authors:  Jerry H Gurwitz; Terry S Field; James Judge; Paula Rochon; Leslie R Harrold; Cynthia Cadoret; Monica Lee; Kathleen White; Jane LaPrino; Janet Erramuspe-Mainard; Martin DeFlorio; Linda Gavendo; Jill Auger; David W Bates
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

2.  Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.

Authors:  Paul Hougland; Wu Xu; Steve Pickard; Carol Masheter; Scott D Williams
Journal:  Med Care       Date:  2006-07       Impact factor: 2.983

Review 3.  Epidemiology of medication-related adverse events in nursing homes.

Authors:  Steven M Handler; Rollin M Wright; Christine M Ruby; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2006-09

4.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

5.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

6.  The impact of computerized physician order entry on medication error prevention.

Authors:  D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape
Journal:  J Am Med Inform Assoc       Date:  1999 Jul-Aug       Impact factor: 4.497

7.  Adverse drug events in ambulatory care.

Authors:  Tejal K Gandhi; Saul N Weingart; Joshua Borus; Andrew C Seger; Josh Peterson; Elisabeth Burdick; Diane L Seger; Kirstin Shu; Frank Federico; Lucian L Leape; David W Bates
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

8.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D C Classen; S L Pestotnik; R S Evans; J F Lloyd; J P Burke
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

9.  Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.

Authors:  D W Bates; L L Leape; D J Cullen; N Laird; L A Petersen; J M Teich; E Burdick; M Hickey; S Kleefield; B Shea; M Vander Vliet; D L Seger
Journal:  JAMA       Date:  1998-10-21       Impact factor: 56.272

10.  Incidence and preventability of adverse drug events in hospitalized adults.

Authors:  D W Bates; L L Leape; S Petrycki
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

View more
  16 in total

1.  A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Authors:  Miney Paquette; Daniel M Witt; Anne Holbrook; Jane Skov; Jack Ansell; Holger J Schünemann; Wojtek Wiercioch; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-05-28

2.  Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies.

Authors:  Lisa Dolovich; Zubin Austin; Nancy Waite; Feng Chang; Barbara Farrell; Kelly Grindrod; Sherilyn Houle; Lisa McCarthy; Lori MacCallum; Beth Sproule
Journal:  Can Pharm J (Ott)       Date:  2018-12-25

3.  Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.

Authors:  Martina Maříková; Zuzana Očovská; Vladimír Nerad; Aleš Antonín Kuběna; Vladimír Blaha; Jiří Vlček
Journal:  Int J Clin Pharm       Date:  2021-03-24

Review 4.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

Review 5.  Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review.

Authors:  Médéa Locquet; Germain Honvo; Véronique Rabenda; Thierry Van Hees; Jean Petermans; Jean-Yves Reginster; Olivier Bruyère
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

Review 6.  Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis.

Authors:  Munil Lee; Mei Wang; Jiayu Liu; Anne Holbrook
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

7.  Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic.

Authors:  Zuzana Očovská; Martina Maříková; Jaromír Kočí; Jiří Vlček
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

8.  Assessing prescribing of NSAIDs, antiplatelets, and anticoagulants in Canadian family medicine using chart review.

Authors:  Kevin Hamilton; Christine Davis; Jamie Falk; Alex Singer; Shawn Bugden
Journal:  Int J Clin Pharm       Date:  2016-06-24

9.  Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort study.

Authors:  Kerstin Hogg; Bharat Bahl; Meriem Latrous; Sarina Scaffidi Argentina; Jesse Thompson; Aasil Ayyaz Chatha; Lana Castellucci; Ian G Stiell
Journal:  CMAJ Open       Date:  2015-12-04

10.  Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario.

Authors:  Petros Pechlivanoglou; Lusine Abrahamyan; Linda MacKeigan; Giulia P Consiglio; Lisa Dolovich; Ping Li; Suzanne M Cadarette; Valeria E Rac; Jonghyun Shin; Murray Krahn
Journal:  BMC Health Serv Res       Date:  2016-11-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.